The Centers for Medicare and Medicaid Services (CMS) plans to begin paying for biosimilars through its Part B,Part D and state coverage policies by this summer, according to a question-and-answer document released in April.
The U.S.Department of Health and Human Services released Positive Spin, a comprehensive digital educational tool that uses storytelling to promote HIV treatment.
Scientists at Georgia Institute ofTechnology have developed a needle-free vaccine against measles.
Researchers have identified a Parkinson’s gene that is associated with lung cancer.
Novo Nordisk has launched Novoeight (antihemophilic factor [recombinant]) in the U.S. for people living with hemophilia A.
A new experimental drug could boost the immune system in older adults by as much as 20 percent, as well as help them to delay other aging effects.
The U.S. Food and Drug Administration(FDA) has finalized three guidance documents outlining its expectations for biosimilars.
Octapharma USA has launched the Octapharma Co-Pay AssistanceProgram available to von Willebrand’s disease patients who are currently receiving Wilate (von Willebrand factor/coagulation factor VIII complex[human]) or have a prescription to begin therapy.
Results from a human trial of GlaxoSmithKline’s Ebola vaccine show it is safe and generates an immune response.
The U.S. Department of Health and Human Services has launched a $133 million initiative to reduce prescription opioid and heroin-related overdose, death and dependence.
An international team of researchers has identified a gene that may be a missing link between overactive and underactive immune activity, and that may also play a key role in autoimmune diseases.
In response to the national measles outbreak, the American Academy of Pediatrics has released updated measles guidelines on its website.
